| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |